Trial Profile
Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD) in Patients With Acute on Chronic Hepatitis (AOCH)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Extracorporeal hepatocyte-based therapy (Primary)
- Indications Hepatitis; Liver failure
- Focus Adverse reactions; Therapeutic Use
- Sponsors Vital Therapies
- 07 Dec 2013 New trial record